298 related articles for article (PubMed ID: 17720709)
1. Nucleosome and transcription activator antagonism at human beta-globin locus control region DNase I hypersensitive sites.
Kim A; Song SH; Brand M; Dean A
Nucleic Acids Res; 2007; 35(17):5831-8. PubMed ID: 17720709
[TBL] [Abstract][Full Text] [Related]
2. Requirements for utilization of CREB binding protein by hypersensitive site two of the beta-globin locus control region.
Johnson KD; Norton JE; Bresnick EH
Nucleic Acids Res; 2002 Apr; 30(7):1522-30. PubMed ID: 11917012
[TBL] [Abstract][Full Text] [Related]
3. The role of transcriptional activator GATA-1 at human beta-globin HS2.
Cho Y; Song SH; Lee JJ; Choi N; Kim CG; Dean A; Kim A
Nucleic Acids Res; 2008 Aug; 36(14):4521-8. PubMed ID: 18586828
[TBL] [Abstract][Full Text] [Related]
4. NF-E2 disrupts chromatin structure at human beta-globin locus control region hypersensitive site 2 in vitro.
Armstrong JA; Emerson BM
Mol Cell Biol; 1996 Oct; 16(10):5634-44. PubMed ID: 8816476
[TBL] [Abstract][Full Text] [Related]
5. Requirement of an E1A-sensitive coactivator for long-range transactivation by the beta-globin locus control region.
Forsberg EC; Johnson K; Zaboikina TN; Mosser EA; Bresnick EH
J Biol Chem; 1999 Sep; 274(38):26850-9. PubMed ID: 10480893
[TBL] [Abstract][Full Text] [Related]
6. Essential role of NF-E2 in remodeling of chromatin structure and transcriptional activation of the epsilon-globin gene in vivo by 5' hypersensitive site 2 of the beta-globin locus control region.
Gong QH; McDowell JC; Dean A
Mol Cell Biol; 1996 Nov; 16(11):6055-64. PubMed ID: 8887635
[TBL] [Abstract][Full Text] [Related]
7. Reconstitution of human beta-globin locus control region hypersensitive sites in the absence of chromatin assembly.
Leach KM; Nightingale K; Igarashi K; Levings PP; Engel JD; Becker PB; Bungert J
Mol Cell Biol; 2001 Apr; 21(8):2629-40. PubMed ID: 11283243
[TBL] [Abstract][Full Text] [Related]
8. Histone acetylation contributes to chromatin looping between the locus control region and globin gene by influencing hypersensitive site formation.
Kim YW; Kim A
Biochim Biophys Acta; 2013 Sep; 1829(9):963-9. PubMed ID: 23607989
[TBL] [Abstract][Full Text] [Related]
9. Chromatin structure at the flanking regions of the human beta-globin locus control region DNase I hypersensitive site-2: proposed nucleosome positioning by DNA-binding proteins including GATA-1.
Davies N; Freebody J; Murray V
Biochim Biophys Acta; 2004 Sep; 1679(3):201-13. PubMed ID: 15358512
[TBL] [Abstract][Full Text] [Related]
10. Structural analysis and mapping of DNase I hypersensitivity of HS5 of the beta-globin locus control region.
Li Q; Zhang M; Duan Z; Stamatoyannopoulos G
Genomics; 1999 Oct; 61(2):183-93. PubMed ID: 10534403
[TBL] [Abstract][Full Text] [Related]
11. The binding of the ubiquitous transcription factor Sp1 at the locus control region represses the expression of beta-like globin genes.
Feng D; Kan YW
Proc Natl Acad Sci U S A; 2005 Jul; 102(28):9896-900. PubMed ID: 15998736
[TBL] [Abstract][Full Text] [Related]
12. A major role for the TATA box in recruitment of chromatin modifying complexes to a globin gene promoter.
Gui CY; Dean A
Proc Natl Acad Sci U S A; 2003 Jun; 100(12):7009-14. PubMed ID: 12773626
[TBL] [Abstract][Full Text] [Related]
13. Enhancer activity of HS2 of the human beta-LCR is modulated by distance from the key nucleosome.
Onishi Y; Kiyama R
Nucleic Acids Res; 2001 Aug; 29(16):3448-57. PubMed ID: 11504883
[TBL] [Abstract][Full Text] [Related]
14. Acetylation of a specific promoter nucleosome accompanies activation of the epsilon-globin gene by beta-globin locus control region HS2.
Gui CY; Dean A
Mol Cell Biol; 2001 Feb; 21(4):1155-63. PubMed ID: 11158302
[TBL] [Abstract][Full Text] [Related]
15. Expression of GATA-1 in a non-hematopoietic cell line induces beta-globin locus control region chromatin structure remodeling and an erythroid pattern of gene expression.
Layon ME; Ackley CJ; West RJ; Lowrey CH
J Mol Biol; 2007 Feb; 366(3):737-44. PubMed ID: 17196618
[TBL] [Abstract][Full Text] [Related]
16. A WW domain-binding motif within the activation domain of the hematopoietic transcription factor NF-E2 is essential for establishment of a tissue-specific histone modification pattern.
Kiekhaefer CM; Boyer ME; Johnson KD; Bresnick EH
J Biol Chem; 2004 Feb; 279(9):7456-61. PubMed ID: 14597626
[TBL] [Abstract][Full Text] [Related]
17. Hypersensitive site 2 specifies a unique function within the human beta-globin locus control region to stimulate globin gene transcription.
Bungert J; Tanimoto K; Patel S; Liu Q; Fear M; Engel JD
Mol Cell Biol; 1999 Apr; 19(4):3062-72. PubMed ID: 10082573
[TBL] [Abstract][Full Text] [Related]
18. Expression-dependent perturbation of nucleosomal phases at HS2 of the human beta-LCR: possible correlation with periodic bent DNA.
Onishi Y; Wada-Kiyama Y; Kiyama R
J Mol Biol; 1998 Dec; 284(4):989-1004. PubMed ID: 9837721
[TBL] [Abstract][Full Text] [Related]
19. Synergistic and additive properties of the beta-globin locus control region (LCR) revealed by 5'HS3 deletion mutations: implication for LCR chromatin architecture.
Fang X; Sun J; Xiang P; Yu M; Navas PA; Peterson KR; Stamatoyannopoulos G; Li Q
Mol Cell Biol; 2005 Aug; 25(16):7033-41. PubMed ID: 16055715
[TBL] [Abstract][Full Text] [Related]
20. Structural and functional cross-talk between a distant enhancer and the epsilon-globin gene promoter shows interdependence of the two elements in chromatin.
McDowell JC; Dean A
Mol Cell Biol; 1999 Nov; 19(11):7600-9. PubMed ID: 10523648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
